Mammalian target of rapamycin and head and neck squamous cell carcinoma

Yu Min Liao, Charles Kim, Yun Yen

Research output: Contribution to journalReview article

22 Citations (Scopus)

Abstract

Head and neck squamous cell carcinoma (HNSCC), a significant cause of cancer deaths worldwide, has multiple stepwise malignant evolutions. Mammalian target of rapamycin (mTOR) plays a critical role in tumor development, invasion, metastasis and angiogenesis that impact local recurrence and survival. mTOR can also act as a biomarker for personalized adjuvant therapy. In in vivo and in vitro studies, mTOR inhibitor suppresses tumor growth and sensitizes HNSCC to radiation, cytotoxic agents and epidermoid growth factor receptor inhibitors. We have reviewed the pathogenesis of HNSCC, mTOR pathway, mTOR inhibitor and the role of mTOR in HNSCC.

Original languageEnglish
Article number22
JournalHead and Neck Oncology
Volume3
Issue number1
DOIs
Publication statusPublished - Apr 26 2011
Externally publishedYes

Fingerprint

Sirolimus
Neoplasms
Growth Factor Receptors
Cytotoxins
Carcinoma, squamous cell of head and neck
Cause of Death
Biomarkers
Radiation
Neoplasm Metastasis
Recurrence
Growth

ASJC Scopus subject areas

  • Otorhinolaryngology
  • Oncology

Cite this

Mammalian target of rapamycin and head and neck squamous cell carcinoma. / Liao, Yu Min; Kim, Charles; Yen, Yun.

In: Head and Neck Oncology, Vol. 3, No. 1, 22, 26.04.2011.

Research output: Contribution to journalReview article

@article{2219294ce5b449ebbee6d45a6e20059f,
title = "Mammalian target of rapamycin and head and neck squamous cell carcinoma",
abstract = "Head and neck squamous cell carcinoma (HNSCC), a significant cause of cancer deaths worldwide, has multiple stepwise malignant evolutions. Mammalian target of rapamycin (mTOR) plays a critical role in tumor development, invasion, metastasis and angiogenesis that impact local recurrence and survival. mTOR can also act as a biomarker for personalized adjuvant therapy. In in vivo and in vitro studies, mTOR inhibitor suppresses tumor growth and sensitizes HNSCC to radiation, cytotoxic agents and epidermoid growth factor receptor inhibitors. We have reviewed the pathogenesis of HNSCC, mTOR pathway, mTOR inhibitor and the role of mTOR in HNSCC.",
author = "Liao, {Yu Min} and Charles Kim and Yun Yen",
year = "2011",
month = "4",
day = "26",
doi = "10.1186/1758-3284-3-22",
language = "English",
volume = "3",
journal = "Head and Neck Oncology",
issn = "1758-3284",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Mammalian target of rapamycin and head and neck squamous cell carcinoma

AU - Liao, Yu Min

AU - Kim, Charles

AU - Yen, Yun

PY - 2011/4/26

Y1 - 2011/4/26

N2 - Head and neck squamous cell carcinoma (HNSCC), a significant cause of cancer deaths worldwide, has multiple stepwise malignant evolutions. Mammalian target of rapamycin (mTOR) plays a critical role in tumor development, invasion, metastasis and angiogenesis that impact local recurrence and survival. mTOR can also act as a biomarker for personalized adjuvant therapy. In in vivo and in vitro studies, mTOR inhibitor suppresses tumor growth and sensitizes HNSCC to radiation, cytotoxic agents and epidermoid growth factor receptor inhibitors. We have reviewed the pathogenesis of HNSCC, mTOR pathway, mTOR inhibitor and the role of mTOR in HNSCC.

AB - Head and neck squamous cell carcinoma (HNSCC), a significant cause of cancer deaths worldwide, has multiple stepwise malignant evolutions. Mammalian target of rapamycin (mTOR) plays a critical role in tumor development, invasion, metastasis and angiogenesis that impact local recurrence and survival. mTOR can also act as a biomarker for personalized adjuvant therapy. In in vivo and in vitro studies, mTOR inhibitor suppresses tumor growth and sensitizes HNSCC to radiation, cytotoxic agents and epidermoid growth factor receptor inhibitors. We have reviewed the pathogenesis of HNSCC, mTOR pathway, mTOR inhibitor and the role of mTOR in HNSCC.

UR - http://www.scopus.com/inward/record.url?scp=79955025748&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955025748&partnerID=8YFLogxK

U2 - 10.1186/1758-3284-3-22

DO - 10.1186/1758-3284-3-22

M3 - Review article

C2 - 21513566

AN - SCOPUS:79955025748

VL - 3

JO - Head and Neck Oncology

JF - Head and Neck Oncology

SN - 1758-3284

IS - 1

M1 - 22

ER -